These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
818 related items for PubMed ID: 11536148
21. Restricted processing of CD16a/Fc γ receptor IIIa N-glycans from primary human NK cells impacts structure and function. Patel KR, Roberts JT, Subedi GP, Barb AW. J Biol Chem; 2018 Mar 09; 293(10):3477-3489. PubMed ID: 29330305 [Abstract] [Full Text] [Related]
22. Fc galactosylation follows consecutive reaction kinetics and enhances immunoglobulin G hexamerization for complement activation. Wei B, Gao X, Cadang L, Izadi S, Liu P, Zhang HM, Hecht E, Shim J, Magill G, Pabon JR, Dai L, Phung W, Lin E, Wang C, Whang K, Sanchez S, Oropeza J, Camperi J, Zhang J, Sandoval W, Zhang YT, Jiang G. MAbs; 2021 Mar 09; 13(1):1893427. PubMed ID: 33682619 [Abstract] [Full Text] [Related]
23. Terminal sugars of Fc glycans influence antibody effector functions of IgGs. Raju TS. Curr Opin Immunol; 2008 Aug 09; 20(4):471-8. PubMed ID: 18606225 [Abstract] [Full Text] [Related]
24. Fc-glycosylation of IgG1 is modulated by B-cell stimuli. Wang J, Balog CI, Stavenhagen K, Koeleman CA, Scherer HU, Selman MH, Deelder AM, Huizinga TW, Toes RE, Wuhrer M. Mol Cell Proteomics; 2011 May 09; 10(5):M110.004655. PubMed ID: 21372248 [Abstract] [Full Text] [Related]
26. Galactose supplementation enhance sialylation of recombinant Fc-fusion protein in CHO cell: an insight into the role of galactosylation in sialylation. Liu J, Wang J, Fan L, Chen X, Hu D, Deng X, Poon HF, Wang H, Liu X, Tan WS. World J Microbiol Biotechnol; 2015 Jul 09; 31(7):1147-56. PubMed ID: 25931375 [Abstract] [Full Text] [Related]
27. Variations in oligosaccharide-protein interactions in immunoglobulin G determine the site-specific glycosylation profiles and modulate the dynamic motion of the Fc oligosaccharides. Wormald MR, Rudd PM, Harvey DJ, Chang SC, Scragg IG, Dwek RA. Biochemistry; 1997 Feb 11; 36(6):1370-80. PubMed ID: 9063885 [Abstract] [Full Text] [Related]
28. IgG fc N-glycosylation changes in Lambert-Eaton myasthenic syndrome and myasthenia gravis. Selman MH, Niks EH, Titulaer MJ, Verschuuren JJ, Wuhrer M, Deelder AM. J Proteome Res; 2011 Jan 07; 10(1):143-52. PubMed ID: 20672848 [Abstract] [Full Text] [Related]
29. Impact of Fc N-glycan sialylation on IgG structure. Zhang Z, Shah B, Richardson J. MAbs; 2019 Jan 07; 11(8):1381-1390. PubMed ID: 31411531 [Abstract] [Full Text] [Related]
30. Lectin analysis of human immunoglobulin G N-glycan sialylation. Dalziel M, McFarlane I, Axford JS. Glycoconj J; 1999 Dec 07; 16(12):801-7. PubMed ID: 11133020 [Abstract] [Full Text] [Related]
31. Comparisons of the glycosylation of a monoclonal antibody produced under nominally identical cell culture conditions in two different bioreactors. Kunkel JP, Jan DC, Butler M, Jamieson JC. Biotechnol Prog; 2000 Dec 07; 16(3):462-70. PubMed ID: 10835250 [Abstract] [Full Text] [Related]
32. CD16a with oligomannose-type N-glycans is the only "low-affinity" Fc γ receptor that binds the IgG crystallizable fragment with high affinity in vitro. Subedi GP, Barb AW. J Biol Chem; 2018 Oct 26; 293(43):16842-16850. PubMed ID: 30213862 [Abstract] [Full Text] [Related]
34. Antibody glycosylation and its impact on the pharmacokinetics and pharmacodynamics of monoclonal antibodies and Fc-fusion proteins. Liu L. J Pharm Sci; 2015 Jun 26; 104(6):1866-1884. PubMed ID: 25872915 [Abstract] [Full Text] [Related]